KV9.1, a member of the voltage-gated potassium channel family, plays an integral role in the electrical signaling of various cell types. Due to its function in modulating cellular excitability, understanding the regulation of KV9.1 expression is of significant interest in the field of molecular biology. The expression of KV9.1 can be influenced by a diverse array of chemical activators, each with unique mechanisms of action that can lead to the upregulation of this potassium channel. For instance, certain compounds can alter the epigenetic landscape surrounding the KV9.1 gene, thereby facilitating or impeding transcriptional activity. Epigenetic modifications such as DNA methylation and histone acetylation are dynamic processes that respond to various stimuli, including the presence of specific biochemical agents. Compounds like 5-Azacytidine and Trichostatin A are known to modify these epigenetic marks, potentially leading to the increased expression of genes like KV9.1. Other substances, such as vitamin D3 and retinoic acid, operate through ligand-receptor interactions, with receptors acting as transcription factors that bind to DNA sequences in the regulatory regions of KV9.1, thereby promoting gene transcription.
In addition to these epigenetic and receptor-mediated pathways, intracellular signaling cascades also play a critical role in the regulation of KV9.1 expression. Forskolin, for example, increases the cellular concentration of cyclic AMP (cAMP), a secondary messenger that activates protein kinase A (PKA). Activated PKA can then phosphorylate transcription factors like CREB, which binds to cAMP response elements in the promoter regions of target genes, including KV9.1, to stimulate their expression. Moreover, dietary components such as Sulforaphane, Curcumin, and Resveratrol have been studied for their ability to induce genetic expression. These compounds engage various intracellular pathways that can lead to the activation of transcription factors or the release of gene repression, thereby potentially stimulating the production of KV9.1. While the specific effects of these activators on KV9.1 expression would require empirical validation, they represent a fascinating aspect of gene regulation that underscores the complexity of cellular function and the intricacies of genetic control mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound may demethylate CpG islands within the KV9.1 promoter region, thereby removing epigenetic silencing and specifically upregulating KV9.1 gene transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Could hyperacetylate histones around the KV9.1 locus, increasing chromatin accessibility to transcription machinery and specifically stimulating KV9.1 gene expression. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Might bind to vitamin D response elements (VDREs) upstream of KV9.1, recruiting coactivators to enhance transcriptional activity and elevate KV9.1 levels. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
By elevating intracellular cAMP, Forskolin may activate the cAMP response element-binding (CREB) pathway, leading to an increase in KV9.1 expression via CREB-mediated transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Could engage retinoic acid receptors that interact with retinoic acid response elements (RAREs) in the KV9.1 promoter to stimulate KV9.1 synthesis. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
May activate the Nrf2 pathway and subsequently induce antioxidant response elements (AREs) that could be present in the KV9.1 gene promoter, upregulating KV9.1 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Might attenuate NF-κB signaling, leading to decreased repression of target genes, including a possible effect on the transcriptional upregulation of KV9.1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Could activate the SIRT1 pathway, leading to the deacetylation of transcriptional repressors and subsequent transcriptional activation of KV9.1. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
Might induce global hyperacetylation of histones, including those near KV9.1, enhancing the accessibility of the promoter region and stimulating KV9.1 expression. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $107.00 | 3 | |
Through antagonism of the mineralocorticoid receptor, it may lead to transcriptional changes that include the upregulation of potassium channel genes such as KV9.1. |